DIRECTOR OF THE ONCOLOGY CENTER AT KING SAUD UNIVERSITY MEDICAL CITY AND CHAIRMAN OF SAUDI SOCIETY OF GI ONCOLOGY, RIYADH
About Our Speaker
Dr. Alghamdi then pursued specialized training in Medical Oncology at the Tom Baker Cancer Center in Calgary, Alberta, Canada, where he completed his residency and fellowship in 2015 and 2017, respectively. Dr. Alghamdi obtained his Medical Oncology Board certification from the Royal College of Physicians and Surgeons in Canada in 2016.
After returning to Saudi Arabia, he served as a locum consultant at the Tom Baker Cancer Center before joining King Saud University Medical City in 2019 as a medical oncologist. His leadership roles include serving as program director for the medical oncology fellowship and head of the medical oncology department.
Currently, Dr. Alghamdi holds the position of director of the Oncology Center at King Saud University Medical City and serves as the chairman of the Saudi Society of GI Oncology since March 2022. His expertise and dedication contribute significantly to the field of oncology in both academic and clinical settings.
This webinar focuses on long-term outcomes in CCA achieved with 2L targeted treatments.